Ledderhose Disease – Long Term Effects of Radiotherapy Treatment. LedRad LTE – Study

Brief Title

Ledderhose Disease - Long Term Effects of Radiotherapy Treatment. LedRad LTE - Study

Official Title

Ledderhose Disease - Long Term Effects of Radiotherapy Treatment. LedRad LTE - Study

Brief Summary

      The aim of the LedRad LTE study is to determine the current complaints, late side effects and
      satisfaction of patients who were treated with radiotherapy for Ledderhose disease at least
      two years ago.
    



Study Type

Observational


Primary Outcome

Current pain

Secondary Outcome

 Worst pain

Condition

Ledderhose Disease

Intervention

Radiotherapy


Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Radiation

Estimated Enrollment

68

Start Date

May 13, 2019

Completion Date

January 31, 2020

Primary Completion Date

January 31, 2020

Eligibility Criteria

        Patients treated with radiotherapy for Ledderhose disease at the UMCG at least 2 years ago
      

Gender

All

Ages

18 Years - N/A

Accepts Healthy Volunteers

No

Contacts

, , 

Location Countries

Netherlands

Location Countries

Netherlands

Administrative Informations


NCT ID

NCT04229147

Organization ID

RT2019-09


Responsible Party

Principal Investigator

Study Sponsor

University Medical Center Groningen


Study Sponsor

, , 


Verification Date

September 2020